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Abstract 3-Hydroxy-3-methylglutaric aciduria is a rare
human autosomal recessive disorder caused by deficiency
of 3-hydroxy-3-methylglutaryl CoA lyase (HL). This
mitochondrial enzyme catalyzes the common final step of
leucine degradation and ketogenesis. Acute symptoms
include vomiting, seizures and lethargy, accompanied by
metabolic acidosis and hypoketotic hypoglycaemia. Such
organs as the liver, brain, pancreas, and heart can also be
involved. However, the pathophysiology of this disease is
only partially understood. We measured mRNA levels,
protein expression and enzyme activity of human HMG-
CoA lyase from liver, kidney, pancreas, testis, heart,
skeletal muscle, and brain. Surprisingly, the pancreas is,
after the liver, the tissue with most HL activity. However, in
heart and adult brain, HL activity was not detected in the
mitochondrial fraction. These findings contribute to our
understanding of the enzyme function and the consequen-
ces of its deficiency and suggest the need for assessment of
pancreatic damage in these patients.
Abbreviations
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3-Hydroxy-3-methylglutaric aciduria (MIM 246450) is a
rare human autosomal recessive disorder caused by
deficiency of 3-hydroxy-3-methylglutaryl CoA lyase
(HMG-CoA lyase, HL, EC 4.1.3.4) (Faull et al. 1976).
This mitochondrial enzyme catalyzes the cleavage of
HMG-CoA to form acetyl-CoA and acetoacetate, which
is the common final step in leucine degradation and
ketogenesis.
The disease usually appears in the first year of life after
a fasting period or during intercurrent illness. Acute
symptoms include vomiting, seizures and lethargy, ac-
companied by metabolic acidosis, hypoketotic hypogly-
c a e m i aa n dac h a r a c t e r i s t i cp attern of elevated urinary
organic acid metabolites (Gibson et al. 1988;S c h u t g e n se t
al. 1979; Wysocki and Hahnel 1986). Such organs as the
liver and brain are frequently affected, and occasionally
the pancreas and heart can also be involved (Gibson et al.
1994; Leung et al. 2009;M u r o ie ta l .2000; Urganci et al.
2001; Wilson et al. 1984; Zafeiriou et al. 2007; Zoghbi et
al. 1986).
The pathophysiology of this disease is only partially
understood. It may be explained by the deficit of an
alternative energy source (ketone bodies), the intracellular
accumulation of toxic organic acids or fatty acids or
secondary carnitine deficiency (Kahler et al. 1994; Mitchell
et al. 1995; Leung et al. 2009). However, these interpreta-
tions were not based on a thorough understanding of the
expression or activity of HL in the affected tissues. To our
knowledge, HL has been examined only in liver, leukocytes
and fibroblasts (Ashmarina et al. 1994; Wysocki and
Hahnel 1976a; Wysocki and Hahnel 1976b) but not in
other human tissues. This report is the first study of mRNA
levels, protein expression and enzyme activity of human
HMG-CoA lyase in kidney, pancreas, testis, heart, skeletal
muscle, and brain. The results may improve our under-
standing of the enzyme function and the involvement of
these organs in 3-hydroxy-3-methylglutaric aciduria.
Materials and methods
HL mRNA
HL mRNA was measured in Multiple Tissue cDNA (MTC)
panels (Clontech) by a Real-Time quantitative PCR method
using a TaqMan Gene Expression Assay (Assay HMGCL:
Hs00609306_m1AssayGAPDH:Hs99999905_m1)(Applied
Biosystems). The levels of HL mRNAwas calculated relative
to the GAPDH control by the ΔΔCt method. The level of
expression HL in skeletal muscle was arbitrarily taken as
the calibrator to normalize the other tissues.
HL protein analysis
Human tissues: liver, kidney, pancreas, testis, heart, skeletal
muscle, and brain were obtained within 10–12 h post
mortem at autopsy from two male subjects at the
Department of Pathology of our University. They were 65
and 70 years old, and representative samples of organs of
approximately 1–2 g were taken from each subject. To
minimize protein degradation, the bodies were kept at 4°C
until autopsy and all the tissues were immediately shock-
frozen in N2 and stored at −80°C until use.
To isolate the mitochondrial fraction from human tissues,
we performed subcellular separation as described by
Clinkenbeard et al. (1975). Mitochondrial proteins separated
on a 15% SDS-PAGE were transferred to a 0.45-μM
nitrocellulose membrane by transfer blot. The membranes
were probed with a mouse monoclonal antibody against HL
(Abnova) (1:1,000 dilution) and revealed with the kit
SuperSignal West Dura Extended Duration substrate
(Thermo Scientific) using a peroxidase-conjugated secondary
anti-mouse antibody (Sigma, 1:1,000). The protein bands
were quantified using Scion ImageJ v1.39u software (Scion)
and normalized to micrograms of total protein obtained from
10 mg of tissue. The density of the band corresponding to
the liver was taken as 100%.
HL activity
After subcellular separation, 20 μl of mitochondrial fraction
of different tissues (about 200 μg of protein) was used to
measure enzymatic activity. HMG–CoA lyase activity was
assayed by the spectrophotometric assay described by
Wanders et al. (1988), which measures the amounts of
acetoacetate produced. The level of activity was expressed
as mU/g wet weight tissue (one milliunit equals 1 nmol of
substrate converted/min).
PAP measurements
Serum samples were collected in acute and inter-crisis
periods from 15 patients with 3-hydroxy-3-methylglutaric
aciduria and stored at −20°C. All patients were diagnosed
biochemically, and most of them were also diagnosed
genetically (Table 1). Human serum PAP (pancreatitis
associated protein) concentration was determined in control
and patients by a kit based on a sandwich immunoenzy-
matic system (PancrePAP, Dynabio).
Results
HL mRNA was detected in all the tissues studied, albeit in
widely differing amounts. Tissues with the highest expres-
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Fig.1a: [liver 112.2 arbitrary units (100%) pancreas 43.5
(39%), kidney 17.56 (16%), testis 26.81 (24%), heart 2.96
(2,6%), brain 2.26 (2%), and skeletal muscle 1 (0.89%)].
The highest protein levels were found in human liver
(100%), followed by pancreas (89%), testis (60%), kidney
(42%), and skeletal muscle (36%); a weak signal was
detected in heart (2%) and brain (1.8%) (Fig 1b). The
enzyme activity was measured in the mitochondrial
fraction. The liver had the highest activity (128.86 mU/g
of wet weight tissue, 100%), followed by pancreas
(58.49 mU/g, 45%), kidney (42.48 mU/g, 33%), testis
(20.23 mU/g, 16%), and skeletal muscle (12.6 mU/g,
9,7%). HL enzyme activity was not detected in heart or
brain (Fig. 1c).
The values of PAP in patients varied between 5.31–
31.87 ng/mL (Table 1) within a normal range (<50 ng/mL)
(Desjeux et al. 2002). Simultaneously, we also measured
PAP protein in 11 normal subjects as controls, and no
differences (range 6.12–32.61 ng/mL) were found.
Discussion
This is the first time that a complete study of mRNA, protein
and enzymatic activity of HL has been reported in a broad
range of human tissues. The findings on the expression level
and enzymatic activity of HL in these tissues may help us
to understand the pathophysiology of HL deficiency.
Our results show that the liver has the highest HL
activity, followed by pancreas. Both organs showed high
levels of mRNA, protein and HL enzyme activity. The liver
is the organ most frequently affected in this deficiency,
although involvement is usually mild, with elevated trans-
aminases and hepatomegaly (Urganci et al. 2001; Wysocki
and Hahnel 1986). Since the liver does not use ketone
bodies as a source of energy (Robinson and Williamson
1980), its deficit is not the cause of the disease. However,
ketogenesis is more active in the liver and the blockage of
this pathway could result in an accumulation of toxic
intermediate metabolites. Recently, Leipnitz et al. (2009)
have demonstrated in vitro the oxidative stress caused in the
liver by the accumulation of organic acids in this
deficiency.
Pancreatitis is a potential complication in patients with
organic acidemias, especially methylmalonic and isovaleric
(Kahler et al. 1994) and less frequently in 3-hydroxy-3-
methylglutaric aciduria (Muroi et al. 2000; Wilson et al.
1984). The presence of HL protein in pancreas has been
reported (MacDonald et al. 2007), but here we demonstrate
that the pancreas has the highest enzymatic activity after the
liver. This finding indicates that the pancreas has a high
ketogenic capacity and suggests that, if ketone bodies
regulate the release of insulin (Biden and Taylor 1983;
Malaisse et al. 1990; Rhodes et al. 1985), some of them
could be produced in the pancreas. In contrast, ketone
bodies do not seem to play an important role as energy
source in this organ. The finding of higher enzymatic
activity in pancreas indicates that it may be more
susceptible to toxic accumulation of metabolites. This
hypothesis has been proposed to explain the pathogenesis
of other organic acidemias of leucine catabolism (Gut et al.
Case Organic acids HMGCL mutation PAP (ng/mL) Reference
P1 + c.109G>T 6.72 Casale et al. 1998
P2 + c.109G>T 8.49 Casale et al. 1998
P3 + c.109G>T/c504_5delCT 20.12
a Menao et al. 2009
31.87
P4 + c.144G>T/c.504_5delCT 5.61 Menao et al. 2009
P5 + c.202_207delCT 9.42 Menao et al. 2009
P6 + c.575T>C 6.17 Menao et al. 2009
P7 + c.109G>T 5.39 Menao et al. 2009
P8 + c.109G>T 7.85 Menao et al. 2009
P9 + c.109G>T/c.825C>G 5.80
a ———
7.37
P10 + c.109G>T 2.13
a Menao et al. 2009
P11 + c.109G>T/c.504_5delCT 5.35
a ———
P12 + c.242G>A 5.93
a ———
P13 + ——— 13.63 ———
P14 + ——— 26.92
a ———
10.46
P15 + ——— 6.16 ———
Table 1 Diagnostic parameters
and pancreatitis associated
protein (PAP) measurements
in patients with 3-hydroxy-3-
methylglutaric aciduria
PAP values in controls (17.46±
8.27 ng/ml, mean±SD, n=11)
+ Elevated organic acids
(3-hydroxy-3-methylglutaric,
3-methylglutaconic,
3-methylglutaric and
3-hydroxy-isovaleric); –— no
data; PAP values measured
in periods intercrisis and
a in acute crisis. PAP values<
50 ng/mL are considered normal
J Inherit Metab Dis (2010) 33:405–410 4071995; Kahler et al. 1994). The possibility of a progressive
deterioration of the pancreas, without evident clinical
manifestations, led us to study the protein PAP in patients
with 3-hydroxy-3-methylglutaric aciduria, in order to detect
and prevent any possible pancreas damage. PAP is a more
sensitive marker of pancreatitis than amylase, whose levels
remain high even in absence of symptoms (Kemppainen et
al. 1996). The serum studies from patients in different
situations of crisis and between crises did not show
pathologic elevations. However, the higher activity of HL
enzyme and the severity of the complications support the
need to monitor the pancreatic function in patients with HL
deficiency.
This study shows that, at different levels of mRNA,
protein and enzymatic activity, HL is not found in the
mitochondria from human brain. The absence of lyase
activity in brain mitochondria is consistent with results
obtained by McGarry and Foster (1969) and Bachhawat et
al. (1955) in rat but it disagrees with the results of Shah
(1982). Ketogenic activity by astrocytes has been de-
s c r i b e d( A u e s t a de ta l .1991; Guzmán and Blázquez
2004), but Auestad et al. (1991) have demonstrated that
acetoacetate is mainly formed in astrocytes by deacylation
of acetoacetyl-CoA and not by the action of the mito-
chondrial HMG-CoA cycle. In conclusion, despite the
difficulties of studying the human brain immediately after
death to avoid protein degradation, HL activity in
mitochondria from adult human brain, if present, would
be minimal. We suggest that the neurological alterations,
frequently associated with this deficiency, are related to
hypoglycaemia and to the absence of the only alternative
substrate to glucose for the brain ketone bodies. Concom-
itantly, our results show that the organic acids would not
be produced in situ, although they could cross the blood–
brain barrier of an immature brain (Wajner et al. 2004)a n d
cause damage.
Dilated cardiomyopathy has been described in two
patients with 3-hydroxy-3-methylglutaric aciduria, one
young male (Gibson et al. 1994) and one adult (Leung et
al. 2009). In this last case, the authors suggest that the
cardiomyopathy results from impaired ketogenesis, intra-
cellular fatty acid accumulation and a secondary carnitine
deficiency. However, we found very little HL in heart
tissue, from which we conclude that it does not regulate the
entry of fatty acids to the heart and thus prevent their
accumulation. Therefore, our results do not support the
hypothesis of local accumulation of organic acids as a cause
of the cardiomyopathy. In HL deficiency, heart disease
could be caused by the lack of an alternative energy
substrate. The heart is a continuously active muscle which
uses various energy substrates depending on their avail-
ability (Kodde et al. 2007). Although ketone bodies are not
an indispensable substrate, the added L-carnitine deficiency,
which is caused by the HL deficiency, could alter the
transport of fatty acids to the mitochondria for oxidation
and the coupling between glycolysis and glucose oxidation
(Allard et al. 2006). L-carnitine supplementation has been
recommended for patients with organic acidurias to allow
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Fig 1 Comparative analysis of mRNA levels, protein expression and
enzymatic activity of HMG-CoA lyase in different human tissues. a
Relative levels of mRNA HL expression in human tissues were
measured by the ΔΔCT method with GAPDH as control. The
expression levels of mRNA HL in skeletal muscle were arbitrarily
taken as the calibrator for all calculations, and all other tissues were
normalized accordingly. The values given are the average of four
meausures, two from each subject. b HL protein expression was
measured in mitochondrial fraction from human tissues. Four tissue
samples were measured, two from each subject. The image shows a
representative immunoblot from HL in different tissues. c HL activity
was measured in the mitochondrial fraction of human tissues
spectrophotometrically. Data are presented as mean±SEM (n=4). Four
tissue samples were measured, two from each subject
408 J Inherit Metab Dis (2010) 33:405–410the elimination of toxic acids (Chalmers et al. 1984), but it
could also improve the heart function.
In HL deficiency, alterations in other organs such as
kidney, testis and skeletal muscle have not been reported,
although in our study the enzymatic activity in kidney was
high or moderately high in testis and skeletal muscle.
Surprisingly, in muscle, although the mRNA levels were
very low, moderate HL activity was measured. Similar
cases are reported in the literature (Lewin et al. 2001),
which suggests that certain tissues may have a lower
turnover of the HL protein versus an unstable mRNA. In
testis, the low activity levels of HL compared with the high
enzyme expression suggest that HL activity could be
regulated after translation in this tissue. All these tissues
use the ketone bodies as an alternative energy source, but
they do not show strong dependence on them (Robinson
and Williamson 1980). Moreover, they are less sensitive to
the accumulation of toxic metabolites, in contrast to the
brain (Wajner et al. 2004) or pancreas (Leung and Chan
2009).
The results reported here help us to understand the
enzyme function and pathophysiology of the 3-hydroxy–
3methylglutaric aciduria. We suggest that pancreatitis
should be included as a possible complication to seek in
patients with HL deficiency, especially during acute
episodes. Moreover, the addition of nutritional factors, such
as L-carnitine, can be essential to prevent the development
of cardiomyopathy.
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